"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Survanta Patient Information including How Should I Take
In this Article
- What is beractant (Survanta)?
- What are the possible side effects of beractant (Survanta)?
- What is the most important information I should know about beractant (Survanta)?
- What should I discuss with my health care provider before my child receives beractant (Survanta)?
- How is beractant given (Survanta)?
- What happens if my child misses a dose (Survanta)?
- What happens if my child receives an overdose (Survanta)?
- What should be avoided after my child receives beractant (Survanta)?
- What other drugs will affect beractant (Survanta)?
- Where can I get more information?
What should I discuss with my health care provider before my child receives beractant (Survanta)?
To best participate in the care of your baby while he or she is in the NICU, carefully follow all instructions provided by your baby's caregivers.
How is beractant given (Survanta)?
Beractant is given directly into the baby's lungs through a breathing tube. Your baby will receive this medication in a neonatal intensive care unit (NICU) or similar hospital setting.
The breathing tube is connected to a ventilator (a machine that moves air in and out of the lungs to help your baby breathe easier and get enough oxygen).
Beractant is given as soon as possible after the baby's birth, usually within minutes or hours.
Your baby's breathing, blood pressure, oxygen levels, and other vital signs will be watched closely during treatment with beractant. This will help your doctor determine how long to continue treatment with beractant. Your child may also need blood tests.
Additional Survanta Information
Report Problems to the Food and Drug Administration
Find out what women really need.